GW9662

N/A

Report date: 2025/03/18 14:23:16
NME

Base Information

Drug NameGW9662
Drug Alias NameGW9662GW-9662
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ antagonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Vienna
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Vienna
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A